Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Amarin Corp Plc (NQ: AMRN)
6.920 USD  UNCHANGED
Official Closing Price  /  Updated: 8:10 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Amarin Corp Plc
 
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Amarin Stays Rangebound, Prescriptions Stagnate
May 23, 2013
Amarin Corporation (NASDAQ: AMRN) has been struggling a lot lately as retail channel prescription data for its EPA capsule Vascepa imply that the drug is starting to slow down its momentum in the... Read More
category AMRN , Bio/Wire
from Bio-Wire.Com
29.3% Return Seen to Date on SmarTrend Amarin Call (AMRN)
May 23, 2013
from Comtex SmarTrend® News Briefs
Amarin Corporation (AMRN) gains on patent news
May 22, 2013
Amarin Corporation plc (NASDAQ: AMRN) added 1.9% to $7.11 after the company announced patent allowance related to combination product of Vascepa and Statin therapy. Share volume was 126,000, compared... Read More
from BAYSTREET RSS FEED
8 Biotechnology Stocks to Sell Now
May 22, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 6 more.
from InvestorPlace - Latest Headlines
Amarin Receive Patent Allowance for Combination Product of Vascepa and Statin Therapy
May 22, 2013
Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that the United... Read More
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
StockCall Pre-Market Review on AMRN, ARAY, ATRS, and ANTH
May 20, 2013
from ACCESSWIRE
Amarin's (AMRN) Vascepa Not in FDA Orange Book for April
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8351078 for the full story. Read More
from StreetInsider.com News Articles
Trading Analysis for Amarin Corporation (AMRN)
May 17, 2013
NEW YORK (AVAFIN) -- Trading of Amarin Corporation options resulted in establishing a new ... Read More
from AVAFIN
7 Biotechnology Stocks to Sell Now
May 15, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
Amarin (AMRN) Sees Early Gains; Stock up 4%
May 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8335159 for the full story. Read More
from StreetInsider.com News Articles
Amarin Reports Solid Vascepa TRx Growth, Stock Holds Its Ground
May 13, 2013
Amarin Reports Solid Vascepa TRx Growth, Stock Holds Its Ground Last week was quite decent for Amarin Corporation (NASDAQ: AMRN) investors, who saw a 6% rally last Friday in reaction to the company’s... Read More
category AMRN , Bio/Wire
from Bio-Wire.Com
Streetinsider.com's Hot Lunchtime Reads 05/10: (WCRX) (AMRN) ((NVDA) (TSLA) (DIS)
May 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8326926 for the full story. Read More
from StreetInsider.com News Articles
MKM Partners Slighly Increases Amarin (AMRN) Vascepa Estimates Post Q1
May 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8326607 for the full story. Read More
from StreetInsider.com News Articles
Amarin Corp Plc (AMRN) Posts Q1 Loss of 41c/Share
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8323703 for the full story. Read More
from StreetInsider.com News Articles
Streetinsider.com's Hot Lunchtime Reads 05/09: (AAPL) (AMRN) (HRG) (MBI)
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8322270 for the full story. Read More
from StreetInsider.com News Articles
Amarin (AMRN) / Omthera (OMTH) Lower Following NEJM Publication
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8322170 for the full story. Read More
from StreetInsider.com News Articles
26.1% Return Seen to Date on SmarTrend Amarin Call (AMRN)
May 08, 2013
from Comtex SmarTrend® News Briefs
Another Disappointing Study For Fish Oil Supplements
May 08, 2013
Another large study has failed to find any benefits for fish oil supplements. The Italian Risk and Prevention Study, published in the New England Journal of Medicine, enrolled 12,513 people who had not... Read More
category NYSE:GSK , NASDAQ:AMRN
from Forbes Real Time
7 Biotechnology Stocks to Sell Now
May 08, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential
May 02, 2013
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential Source: George S. Mack of The Life Sciences Report (5/2/13) http://www.thelifesciencesreport.com/pub/na/15211 In January 2013, The... Read More
category GALE , NVS , ONXX , and 17 more.
from Bio-Wire.Com
Amarin Shares Down 23.7% Since SmarTrend's Sell Call (AMRN)
May 01, 2013
from Comtex SmarTrend® News Briefs
7 Biotechnology Stocks to Sell Now
May 01, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
Amarin (AMRN) Receives FDA Approval for BASF sNDA as Vascepa API
April 30, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8287747 for the full story. Read More
from StreetInsider.com News Articles
Vascepa’s Upward Grind Should Reward Amarin Investors With Stability Ahead of ANCHOR
April 29, 2013
I’ve got to hand it to Amarin Corporation (NASDAQ: AMRN) for its progress on the launch of EPA capsule Vascepa, which was able to make appreciable gains in market share for 14 consecutive weeks.... Read More
category Prime Content , AMRN , Brian L/ Wilson
from Bio-Wire.Com
Amarin Down 31.8% Since SmarTrend Downtrend Call (AMRN)
April 24, 2013
from Comtex SmarTrend® News Briefs
Stocks Hitting 52-Week Lows
April 24, 2013
U.S. Global Investors (NASDAQ: GROW ) shares fell 1.01% to touch a new 52-week low of $2.95. U.S. Global Investors' trailing-twelve-month ROE is 1.51%. PDI (NASDAQ: PDII ) shares dropped 1.76% to... Read More
category Benzinga , 52/Week Lows , PDII , and 7 more.
from Latest Articles from Benzinga.com
Amarin: The Losing Streak Continues (AMRN)
April 24, 2013
from Comtex SmarTrend® News Briefs
7 Biotechnology Stocks to Sell Now
April 24, 2013
 Read More
category NASDAQ:TSRX , NASDAQ:ACHN , NASDAQ:EXEL , and 5 more.
from InvestorPlace - Latest Headlines
StreetInsider.com Pre-Open Movers 4/23: (NFLX) (CZR) (COH) Higher; (RCII) (IOC) (RATE) Lower (more...)
April 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8270915 for the full story. Read More
from StreetInsider.com News Articles
Amarin (AMRN) sNDA for Vascepa Accepted by U.S. FDA
April 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8269668 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here